Diverse patterns of cyclooxygenase-independent metalloproteinase gene regulation in human monocytes

British Journal of Pharmacology

Volumn 163, Issue 8, 2011, Pages 1679-1690

  Reel, Buket ^a,b   Sala Newby, Graciela B ^a   Huang, Wei Chun ^a,c   Newby, Andrew C ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b EGE UNIVERSITY   (Turkey)

^c KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

cyclooxygenase inhibitors; inflammation; metalloproteinases; monocytes; prostaglandins; Toll like receptors

Indexed keywords

CYCLOOXYGENASE 2; FORSKOLIN; GELATINASE A; GELATINASE B; I KAPPA B KINASE INHIBITOR; INTERSTITIAL COLLAGENASE; LIPOPOLYSACCHARIDE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 19; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN SYNTHASE; STROMELYSIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE CONTROL; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PURIFICATION; UPREGULATION; ZYMOGRAPHY;

CELL ADHESION; DINOPROSTONE; FIBRONECTINS; FORSKOLIN; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; METALLOPROTEASES; MONOCYTES; NF-KAPPA B P52 SUBUNIT; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHYTOTHERAPY; PLANT PREPARATIONS; PLASTICS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASES; UP-REGULATION;

EID: 79960903578     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01298.x     Document Type: Article

References (37)

1. Alexander SPH, Mathie A, Peters JA, (2009). Guide to Receptors and Channels (GRAC). 4th edn. Br J Pharmacol 158 (Suppl. 1): S1-S254.
2. Ardans JA, Economou AP, Martinson JM Jr, Zhou M, Wahl LM, (2002). Oxidized low-density and high-density lipoproteins regulate the production of matrix metalloproteinase-1 and -9 by activated monocytes. J Leukoc Biol 71: 1012-1018.
3. Baeuerle PA, Baltimore D, (1996). NF-κB: ten years after. Cell 87: 13-20.
4. Baker AH, Edwards DR, Murphy G, (2002). Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 115: 3719-3727. (Pubitemid 35203598)
5. Bar-Or A, Nuttall RK, Duddy M, Alter A, Kim HJ, Ifergan I, et al,. (2003). Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. Brain 126: 2738-2749. (Pubitemid 37463092)
6. Benbow U, Brinkerhoff CE, (1997). The AP-1 site and MMP gene regulation: what is all the fuss about. Matrix Biol 15: 519-526. (Pubitemid 27190026)
7. Bennett BL, Sasaki DT, Murray BW, O'leary EC, Sakata ST, Xu W, et al,. (2001). SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A 98: 13681-13686. (Pubitemid 33115958)
8. Birkenkamp KU, Tuyt LM, Lummen C, Wierenga AT, Kruijer W, Vellenga E, (2000). The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway. Br J Pharmacol 131: 99-107.
9. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T, (2003). Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253: 269-285.
10. Chase A, Bond M, Crook MF, Newby AC, (2002). Role of nuclear factor-κB activation in metalloproteinase-1, -3 and -9 secretion by human macrophages in vitro and rabbit foam cells produced in vivo. Arterioscler Thromb Vasc Biol 22: 765-771. (Pubitemid 34517787)
11. Cipollone F, Fazia ML, Iezzi A, Cuccurullo C, De Cesare D, Ucchino S, et al,. (2005). Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. Arterioscl Thromb Vasc Biol 25: 1925-1931. (Pubitemid 41243464)
12. Cipollone F, Cicolini G, Bucci M, (2008). Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives. Pharmacol Therapeut 118: 161-180.
13. Corcoran ML, Stetler-Stevenson WG, Brown PD, Wahl LM, (1992). Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J Biol Chem 267: 515-519.
14. Fabunmi RP, Sukhova GK, Sugiyama S, Libby P, (1998). Expression of tissue inhibitor of metalloproteinases-3 in human atheroma and regulation in lesion-associated cells-a potential protective mechanism in plaque stability. Circ Res 83: 270-278. (Pubitemid 28371316)
15. Feaver RE, Gelfand BD, Wang C, Schwartz MA, Blackman BR, (2010). Atheroprone hemodynamics regulate fibronectin deposition to create positive feedback that sustains endothelial inflammation. Circ Res 106: 1703-1711.
16. Hall JP, Davis RJ, (2002). Inhibition of the p38 pathway upregulates macrophage JNK and ERK activities, and the ERK, JNK, and p38 MAP kinase pathways are reprogrammed during differentiation of the murine myeloid M1 cell line. J Cell Biochem 86: 1-11. (Pubitemid 34595007)
17. Jacob SS, Shastry P, Sudhakaran PR, (2002). Monocyte-macrophage differentiation in vitro: modulation by extracellular matrix protein substratum. Mol Cell Biochem 233: 9-17. (Pubitemid 34746104)
18. Khan KM, Howe LR, Falcone DJ, (2004). Extracellular matrix-induced cyclooxygenase-2 regulates macrophage proteinase expression. J Biol Chem 279: 22039-22046. (Pubitemid 38679395)
19. Kishore N, Sommers C, Mathialagan S, Guzova J, Yao M, Hauser S, et al,. (2003). A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts. J Biol Chem 278: 32861-32871. (Pubitemid 37055728)
20. Lehtonen A, Ahlfors H, Veckman V, Miettinen M, Lahesmaa R, Julkunen I, (2007). Gene expression profiling during differentiation of human monocytes to macrophages or dendritic cells. J Leukoc Biol 82: 710-720. (Pubitemid 47367163)
21. Lohi J, Lehti K, Valtanen H, Parks WC, Keski-Oja J, (2000). Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene. Gene 242: 75-86. (Pubitemid 30065091)
22. Matias-Roman S, Galvez BG, Genis L, Yanez-Mo M, De La Rosa G, Sanchez-Mateos P, et al,. (2005). Membrane type 1-matrix metalloproteinase is involved in migration of human monocytes and is regulated through their interaction with fibronectin or endothelium. Blood 105: 3956-3964. (Pubitemid 40656143)
23. Nagase H, Visse R, Murphy G, (2006). Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69: 562-573. (Pubitemid 43139720)
24. Newby AC, (2005). Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 85: 1-31. (Pubitemid 40171256)
25. Newby AC, (2006). Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovasc Res 69: 614-624. (Pubitemid 43140745)
26. Newby AC, (2008). Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. Arterioscler Thromb Vasc Biol 28: 2108-2114.
27. Parks WC, Wilson CL, Lopez-Boado YS, (2004). Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 4: 617-629. (Pubitemid 39025047)
28. Pavlovic S, Du B, Sakamoto K, Khan KM, Natarajan C, Breyer RM, et al,. (2006). Targeting prostaglandin E2 receptors as an alternative strategy to block cyclooxygenase-2-dependent extracellular matrix-induced matrix metalloproteinase-9 expression by macrophages. J Biol Chem 281: 3321-3328. (Pubitemid 43852881)
29. Saunders WB, Bayless KJ, Davis GE, (2005). MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices. J Cell Sci 118: 2325-2340. (Pubitemid 40872853)
30. Shankavaram UT, Lai WC, Netzel-Arnett S, Mangan PR, Ardans JA, Caterina N, et al,. (2001). Monocyte membrane type 1-matrix metalloproteinase. Prostaglandin-dependent regulation and role in metalloproteinase-2 activation. J Biol Chem 276: 19027-19032.
31. Shimizu K, Mitchell RN, Libby P, (2006). Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 26: 987-994. (Pubitemid 43732102)
32. Smart DE, Vincent KJ, Arthur MJ, Eickelberg O, Castellazzi M, Mann J, et al,. (2001). JunD regulates transcription of the tissue inhibitor of metalloproteinases-1 and interleukin-6 genes in activated hepatic stellate cells. J Biol Chem 276: 24414-24421.
33. Sorsa T, Tjaderhane L, Konttinen YT, Lauhio A, Salo T, Lee HM, et al,. (2006). Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 38: 306-321. (Pubitemid 44385100)
34. Stecher VJ, Kaplan JE, Connolly K, Mielens Z, Saelens JK, (1986). Fibronectin in acute and chronic inflammation. Arthritis Rheum 29: 394-399. (Pubitemid 16127274)
35. Taggart CC, Greene CM, Carroll TP, O'neill SJ, Mcelvaney NG, (2005). Elastolytic proteases: inflammation resolution and dysregulation in chronic infective lung disease. Am J Respir Crit Care Med 171: 1070-1076. (Pubitemid 40663716)
36. Vincenti MP, Brinckerhoff CE, (2002). Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res 4: 157-164. (Pubitemid 34460754)
37. Zhang Y, Mccluskey K, Fujii K, Wahl LM, (1998). Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms. J Immunol 161: 3071-3076. (Pubitemid 28425734)